Every year, Mark Chataway (of Baird’s CMC and Hyderus) writes a piece for Pharmaceutical Executive. This year’s piece is on how badly the pharmaceutical industry does with social media (and is co-written with James Ward). It’s already proving highly controversial. “Pharma wants to play the role of a second-grade consumer marketer, not that of a thoughtful citizen,” says Chataway.